The unprecedented plunge in electricity use around the world at the beginning of the global pandemic was tied to shut-down policies and other factors. Surprisingly, the recovery to pre-COVID levels was quite fast and not linked to those same factors.
Provost Persis Drell and Russell Furr, associate vice provost for Environmental Health & Safety, outline the protocols for returning to campus from the upcoming winter break.
The Moderna and Pfizer BioNTech vaccines prevented COVID-19 infection in cancer patients, particularly in those whose treatment concluded more than six months before vaccination, say researchers at Stanford, Harvard and the VA.
Data suggest that between 10% and 30% of those who have had an acute SARS-CoV-2 infection will experience the persistent pattern of symptoms known as long COVID.
Stanford epidemiologist and infectious disease expert Yvonne Maldonado provides an overview of the new vaccine opportunities, the efficacy rates found so far and what you need to know to protect young children.
A Stanford study at a California prison found that although there were more breakthrough COVID-19 infections than before the emergence of the delta variant, vaccinated prison residents had few symptomatic cases.
